|
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
7.889e-199 |
0.54
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
1.496e-194 |
0.54
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
3.024e-129 |
0.54
|
| BKRB1_MACFA |
BDKRB1 |
B1 bradykinin receptor |
3.833e-98 |
0.53
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
2.084e-93 |
0.51
|
| Q8MHZ5_SHEEP |
|
Ghrelin/growth hormone secretagogue receptor |
1.134e-91 |
0.37
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
4.418e-89 |
0.39
|
| CALCA_HUMAN |
CALCA |
Calcitonin gene-related peptide 1 |
4.699e-80 |
0.34
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
2.438e-73 |
0.39
|
| DYR_BOVIN |
DHFR |
Dihydrofolate reductase |
1.935e-67 |
0.40
|
| TRPV4_RAT |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
1.072e-58 |
0.37
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
2.668e-57 |
0.52
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
2.086e-56 |
0.45
|
| CCR3_MACMU |
CCR3 |
C-C chemokine receptor type 3 |
3.751e-51 |
0.41
|
| KDM2A_HUMAN |
KDM2A |
Lysine-specific demethylase 2A |
6.519e-47 |
0.35
|
| CALRL_HUMAN |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
9.826e-45 |
0.35
|
| V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
5.63e-44 |
0.40
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
1.069e-41 |
0.44
|
| V1AR_RAT |
Avpr1a |
Vasopressin V1a receptor |
5.568e-41 |
0.38
|
| SCAF_HHV8P |
ORF17 |
Capsid scaffolding protein |
1.674e-38 |
0.30
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
3.369e-38 |
0.39
|
| PAQR1_HUMAN |
ADIPOR1 |
Adiponectin receptor protein 1 |
3.875e-36 |
0.29
|
| PAQR2_HUMAN |
ADIPOR2 |
Adiponectin receptor protein 2 |
3.875e-36 |
0.29
|
| HRH3_MOUSE |
Hrh3 |
Histamine H3 receptor |
2.584e-33 |
0.32
|
| KDM5C_HUMAN |
KDM5C |
Lysine-specific demethylase 5C |
3.842e-33 |
0.35
|
| FABI_STAAR |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI |
1.422e-32 |
0.32
|
| NK1R_CAVPO |
TACR1 |
Substance-P receptor |
4.791e-31 |
0.34
|
| ACES_MOUSE |
Ache |
Acetylcholinesterase |
2.242e-29 |
0.33
|
| NK2R_BOVIN |
TACR2 |
Substance-K receptor |
3.68e-29 |
0.28
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
4.079e-29 |
0.40
|
| PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
6.405e-26 |
0.44
|
| NMDE2_RAT |
Grin2b |
Glutamate receptor ionotropic, NMDA 2B |
1.669e-25 |
0.35
|
| AGTR1_BOVIN |
AGTR1 |
Type-1 angiotensin II receptor |
9.222e-25 |
0.34
|
| Q1HEC0_RAT |
|
Acetyl-Coenzyme A carboxylase 2 |
1.993e-24 |
0.39
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
3.996e-24 |
0.37
|
| RHOA_HUMAN |
RHOA |
Transforming protein RhoA |
6.482e-24 |
0.34
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
2.847e-23 |
0.29
|
| CAC1H_RAT |
Cacna1h |
Voltage-dependent T-type calcium channel subunit alpha-1H |
5.225e-23 |
0.28
|
| O70424_RAT |
|
Neuropeptide Y-Y2 receptor |
8.429e-23 |
0.36
|
| PPCE_PIG |
PREP |
Prolyl endopeptidase |
2.115e-21 |
0.32
|
| Q5TKS5_STAAU |
fabI |
Enoyl-ACP reductase |
2.446e-21 |
0.32
|
| SC6A7_HUMAN |
SLC6A7 |
Sodium-dependent proline transporter |
2.078e-20 |
0.30
|
| CARP2_CANAX |
SAP2 |
Candidapepsin-2 |
2.382e-20 |
0.33
|
| FABI_ECOLI |
fabI |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI |
4.835e-20 |
0.34
|
| TF7L2_HUMAN |
TCF7L2 |
Transcription factor 7-like 2 |
1.052e-19 |
0.39
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.346e-19 |
0.38
|
| RAD1_HUMAN |
RAD1 |
Cell cycle checkpoint protein RAD1 |
5.576e-19 |
0.30
|
| CAC1G_HUMAN |
CACNA1G |
Voltage-dependent T-type calcium channel subunit alpha-1G |
7.306e-19 |
0.33
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
7.632e-19 |
0.36
|
| HRH3_CAVPO |
HRH3 |
Histamine H3 receptor |
1.137e-18 |
0.36
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
2.259e-18 |
0.38
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
2.983e-18 |
0.40
|
| CTNB1_HUMAN |
CTNNB1 |
Catenin beta-1 |
3.576e-18 |
0.39
|
| PARP6_HUMAN |
PARP6 |
Protein mono-ADP-ribosyltransferase PARP6 |
6.109e-18 |
0.28
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
8.714e-18 |
0.34
|
| Q8JXU8_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.375e-17 |
0.39
|
| NPC1_HUMAN |
NPC1 |
NPC intracellular cholesterol transporter 1 |
3.179e-17 |
0.33
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
3.87e-17 |
0.40
|
| AGTR2_RAT |
Agtr2 |
Type-2 angiotensin II receptor |
1.11e-16 |
0.34
|
| INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
1.11e-16 |
0.41
|
| PAR14_HUMAN |
PARP14 |
Protein mono-ADP-ribosyltransferase PARP14 |
1.11e-16 |
0.30
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
1.11e-16 |
0.33
|
| VGFR2_MOUSE |
Kdr |
Vascular endothelial growth factor receptor 2 |
1.11e-16 |
0.34
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
4.441e-16 |
0.32
|
| OXYR_HUMAN |
OXTR |
Oxytocin receptor |
6.661e-16 |
0.33
|
| DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
8.882e-16 |
0.34
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
2.887e-15 |
0.40
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
4.33e-15 |
0.37
|
| AGTR1_RABIT |
AGTR1 |
Type-1 angiotensin II receptor |
4.441e-15 |
0.34
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
8.438e-15 |
0.50
|
| ACACA_RAT |
Acaca |
Acetyl-CoA carboxylase 1 |
1.144e-14 |
0.39
|
| SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.654e-14 |
0.34
|
| FABP4_HUMAN |
FABP4 |
Fatty acid-binding protein, adipocyte |
1.688e-14 |
0.37
|
| MGLL_HUMAN |
MGLL |
Monoglyceride lipase |
1.943e-14 |
0.36
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
4.208e-14 |
0.50
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
6.772e-14 |
0.33
|
| DPP4_HUMAN |
DPP4 |
Dipeptidyl peptidase 4 |
9.559e-14 |
0.40
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
1.038e-13 |
0.35
|
| PARP2_HUMAN |
PARP2 |
Poly [ADP-ribose] polymerase 2 |
1.291e-13 |
0.32
|
| ANPRA_HUMAN |
NPR1 |
Atrial natriuretic peptide receptor 1 |
1.307e-13 |
0.31
|
| NMT_CANAL |
NMT1 |
Glycylpeptide N-tetradecanoyltransferase |
1.397e-13 |
0.36
|
| SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
2.163e-13 |
0.30
|
| T23O_HUMAN |
TDO2 |
Tryptophan 2,3-dioxygenase |
3.904e-13 |
0.33
|
| B9W6M3_CANDC |
CNA1 |
Serine/threonine-protein phosphatase |
4.353e-13 |
0.35
|
| Q9BJF5_TOXGO |
CDPK1 |
Calmodulin-domain protein kinase 1 |
2.307e-12 |
0.32
|
| Q70GC6_9HEPC |
NS5B |
RNA-directed RNA polymerase |
3.447e-12 |
0.31
|
| VMAT2_MOUSE |
Slc18a2 |
Synaptic vesicular amine transporter |
6.016e-12 |
0.29
|
| DYR_HUMAN |
DHFR |
Dihydrofolate reductase |
7.22e-12 |
0.39
|
| Q9FD53_STREE |
mvaD |
Diphosphomevalonate decarboxylase |
7.901e-12 |
0.32
|
| TRYB1_HUMAN |
TPSAB1 |
Tryptase alpha/beta-1 |
1.687e-11 |
0.30
|
| NK2R_HUMAN |
TACR2 |
Substance-K receptor |
1.704e-11 |
0.35
|
| IKKA_HUMAN |
CHUK |
Inhibitor of nuclear factor kappa-B kinase subunit alpha |
1.758e-11 |
0.39
|
| NK1R_HUMAN |
TACR1 |
Substance-P receptor |
2.428e-11 |
0.33
|
| Q865E1_MACMU |
HRH3 |
Histamine receptor H3 |
3.493e-11 |
0.34
|
| RPA1_HUMAN |
POLR1A |
DNA-directed RNA polymerase I subunit RPA1 |
4.741e-11 |
0.29
|
| BRS3_RAT |
Brs3 |
Bombesin receptor subtype-3 |
5.048e-11 |
0.30
|
| SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
6.637e-11 |
0.34
|
| HPPD_HUMAN |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
6.75e-11 |
0.30
|
| PDE6D_HUMAN |
PDE6D |
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta |
1.181e-10 |
0.32
|
| CP2C9_HUMAN |
CYP2C9 |
Cytochrome P450 2C9 |
1.909e-10 |
0.51
|
| NK2R_RABIT |
TACR2 |
Substance-K receptor |
2.642e-10 |
0.34
|
| ACES_HUMAN |
ACHE |
Acetylcholinesterase |
3.042e-10 |
0.35
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
4.103e-10 |
0.46
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
4.323e-10 |
0.32
|
| ACACB_HUMAN |
ACACB |
Acetyl-CoA carboxylase 2 |
6.826e-10 |
0.39
|
| AAPK2_HUMAN |
PRKAA2 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 |
9.838e-10 |
0.33
|
| KCNH2_HUMAN |
KCNH2 |
Potassium voltage-gated channel subfamily H member 2 |
1.04e-09 |
0.37
|
| SC6A1_HUMAN |
SLC6A1 |
Sodium- and chloride-dependent GABA transporter 1 |
2.735e-09 |
0.29
|
| SFRP1_HUMAN |
SFRP1 |
Secreted frizzled-related protein 1 |
2.847e-09 |
0.30
|
| PDE3B_HUMAN |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
2.984e-09 |
0.34
|
| MK08_RAT |
Mapk8 |
Mitogen-activated protein kinase 8 |
5.067e-09 |
0.32
|
| NPY2R_HUMAN |
NPY2R |
Neuropeptide Y receptor type 2 |
6.048e-09 |
0.36
|
| V1BR_RAT |
Avpr1b |
Vasopressin V1b receptor |
6.086e-09 |
0.30
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
7.071e-09 |
0.43
|
| FAS_HUMAN |
FASN |
Fatty acid synthase |
9.452e-09 |
0.31
|
| PDK2_HUMAN |
PDK2 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial |
1.113e-08 |
0.33
|
| WNK1_HUMAN |
WNK1 |
Serine/threonine-protein kinase WNK1 |
1.28e-08 |
0.30
|
| CNR1_MOUSE |
Cnr1 |
Cannabinoid receptor 1 |
1.546e-08 |
0.33
|
| PDE3A_HUMAN |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
2.73e-08 |
0.34
|
| PTR1_LEIMA |
PTR1 |
Pteridine reductase 1 |
3.103e-08 |
0.28
|
| 5HT3A_HUMAN |
HTR3A |
5-hydroxytryptamine receptor 3A |
3.55e-08 |
0.34
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
4.133e-08 |
0.47
|
| CCNC_HUMAN |
CCNC |
Cyclin-C |
5.157e-08 |
0.34
|
| MK07_HUMAN |
MAPK7 |
Mitogen-activated protein kinase 7 |
5.292e-08 |
0.40
|
| 5HT2B_HUMAN |
HTR2B |
5-hydroxytryptamine receptor 2B |
6.085e-08 |
0.36
|
| PDE9A_RAT |
Pde9a |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
6.349e-08 |
0.32
|
| VMAT2_HUMAN |
SLC18A2 |
Synaptic vesicular amine transporter |
7.608e-08 |
0.29
|
| IKKB_HUMAN |
IKBKB |
Inhibitor of nuclear factor kappa-B kinase subunit beta |
8.267e-08 |
0.39
|
| NPCL1_HUMAN |
NPC1L1 |
NPC1-like intracellular cholesterol transporter 1 |
9.473e-08 |
0.30
|
| S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
1.289e-07 |
0.32
|
| DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
1.477e-07 |
0.39
|
| 5HT3A_CAVPO |
HTR3A |
5-hydroxytryptamine receptor 3A |
1.762e-07 |
0.33
|
| ACES_RAT |
Ache |
Acetylcholinesterase |
1.834e-07 |
0.31
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
2.033e-07 |
0.32
|
| EHMT2_HUMAN |
EHMT2 |
Histone-lysine N-methyltransferase EHMT2 |
2.406e-07 |
0.31
|
| Q8QGU2_CHICK |
FKBP12.6 |
Peptidylprolyl isomerase |
2.869e-07 |
0.28
|
| FOLH1_HUMAN |
FOLH1 |
Glutamate carboxypeptidase 2 |
2.91e-07 |
0.35
|
| PGFRB_MOUSE |
Pdgfrb |
Platelet-derived growth factor receptor beta |
3.39e-07 |
0.34
|
| MK01_MOUSE |
Mapk1 |
Mitogen-activated protein kinase 1 |
3.442e-07 |
0.33
|
| HDA11_HUMAN |
HDAC11 |
Histone deacetylase 11 |
4.228e-07 |
0.33
|
| ETHR_MYCTU |
ethR |
HTH-type transcriptional regulator EthR |
5.87e-07 |
0.31
|
| V1AR_HUMAN |
AVPR1A |
Vasopressin V1a receptor |
7.051e-07 |
0.38
|
| BKRB1_HUMAN |
BDKRB1 |
B1 bradykinin receptor |
8.107e-07 |
0.31
|
| MCHR1_HUMAN |
MCHR1 |
Melanin-concentrating hormone receptor 1 |
9.1e-07 |
0.36
|
| DGAT2_HUMAN |
DGAT2 |
Diacylglycerol O-acyltransferase 2 |
9.523e-07 |
0.31
|
| CCR4_MOUSE |
Ccr4 |
C-C chemokine receptor type 4 |
1.023e-06 |
0.28
|
| FABPH_HUMAN |
FABP3 |
Fatty acid-binding protein, heart |
1.056e-06 |
0.31
|
| NOD1_HUMAN |
NOD1 |
Nucleotide-binding oligomerization domain-containing protein 1 |
1.099e-06 |
0.41
|
| MK03_MOUSE |
Mapk3 |
Mitogen-activated protein kinase 3 |
1.105e-06 |
0.32
|
| S12A2_HUMAN |
SLC12A2 |
Solute carrier family 12 member 2 |
1.106e-06 |
0.28
|
| CASP5_HUMAN |
CASP5 |
Caspase-5 |
1.193e-06 |
0.33
|
| SCN4A_HUMAN |
SCN4A |
Sodium channel protein type 4 subunit alpha |
1.217e-06 |
0.28
|
| V2R_RAT |
Avpr2 |
Vasopressin V2 receptor |
1.423e-06 |
0.38
|
| LOXL2_HUMAN |
LOXL2 |
Lysyl oxidase homolog 2 |
1.784e-06 |
0.31
|
| OPRX_HUMAN |
OPRL1 |
Nociceptin receptor |
1.875e-06 |
0.33
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
2.034e-06 |
0.35
|
| APH1A_HUMAN |
APH1A |
Gamma-secretase subunit APH-1A |
2.193e-06 |
0.35
|
| APH1B_HUMAN |
APH1B |
Gamma-secretase subunit APH-1B |
2.193e-06 |
0.35
|
| NICA_HUMAN |
NCSTN |
Nicastrin |
2.193e-06 |
0.35
|
| PEN2_HUMAN |
PSENEN |
Gamma-secretase subunit PEN-2 |
2.207e-06 |
0.35
|
| ACM3_HUMAN |
CHRM3 |
Muscarinic acetylcholine receptor M3 |
2.21e-06 |
0.35
|
| CP3A4_HUMAN |
CYP3A4 |
Cytochrome P450 3A4 |
2.235e-06 |
0.42
|
| OPRX_CAVPO |
OPRL1 |
Nociceptin receptor |
2.237e-06 |
0.29
|
| PSN2_HUMAN |
PSEN2 |
Presenilin-2 |
2.249e-06 |
0.35
|
| HMOX2_RAT |
Hmox2 |
Heme oxygenase 2 |
2.408e-06 |
0.31
|
| DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
2.522e-06 |
0.40
|
| MDR1B_MOUSE |
Abcb1b |
ATP-dependent translocase ABCB1 |
2.587e-06 |
0.32
|
| AK1BA_HUMAN |
AKR1B10 |
Aldo-keto reductase family 1 member B10 |
2.797e-06 |
0.29
|
| RAD51_HUMAN |
RAD51 |
DNA repair protein RAD51 homolog 1 |
3.716e-06 |
0.30
|
| V1AR_MOUSE |
Avpr1a |
Vasopressin V1a receptor |
3.91e-06 |
0.29
|
| PSN1_HUMAN |
PSEN1 |
Presenilin-1 |
4.035e-06 |
0.35
|
| ACKR3_HUMAN |
ACKR3 |
Atypical chemokine receptor 3 |
4.735e-06 |
0.35
|
| CP2D6_HUMAN |
CYP2D6 |
Cytochrome P450 2D6 |
5.01e-06 |
0.35
|
| ACES_ELEEL |
ache |
Acetylcholinesterase |
5.451e-06 |
0.33
|
| DUS22_HUMAN |
DUSP22 |
Dual specificity protein phosphatase 22 |
5.752e-06 |
0.28
|
| NPSR1_HUMAN |
NPSR1 |
Neuropeptide S receptor |
5.767e-06 |
0.30
|
| AGP1_YEAST |
AGP1 |
General amino acid permease AGP1 |
6.166e-06 |
0.29
|
| SMO_HUMAN |
SMO |
Smoothened homolog |
6.327e-06 |
0.30
|
| NOD2_HUMAN |
NOD2 |
Nucleotide-binding oligomerization domain-containing protein 2 |
6.389e-06 |
0.41
|
| ERN1_HUMAN |
ERN1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 |
8.524e-06 |
0.33
|
| CCR3_RAT |
Ccr3 |
C-C chemokine receptor type 3 |
8.61e-06 |
0.41
|
| CASP4_HUMAN |
CASP4 |
Caspase-4 |
8.628e-06 |
0.33
|
| EGLN1_HUMAN |
EGLN1 |
Egl nine homolog 1 |
9.342e-06 |
0.29
|